NYSE:SHP - ShangPharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$23,300.00 -200.00 (-0.85 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$23,500.00
Today's Range$23,300.00 - $23,300.00
52-Week RangeN/A
Volume1,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
ShangPharma Corporation (ShangPharma) is a China-based holding company. The Company is a pharmaceutical and biotechnology research and development (R&D) outsourcing company. It provides a range of high-quality, integrated services across the drug discovery and development process to international and Chinese pharmaceutical and biotechnology companies. Its services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. It has a diversified and loyal global customer base. In March 2013, the Company completed the merger contemplated by the previously announced Agreement and Plan of Merger (the Merger Agreement), by and among the Company, ShangPharma Holdings Limited (Holdings), ShangPharma Parent Limited (Parent) and ShangPharma Merger Sub Limited (Merger Sub). As a result of the merger, the Company became a wholly owned subsidiary of Parent.

Receive SHP News and Ratings via Email

Sign-up to receive the latest news and ratings for SHP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

ShangPharma (NYSE:SHP) Frequently Asked Questions

What is ShangPharma's stock symbol?

ShangPharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "SHP."

What is the consensus analysts' recommendation for ShangPharma?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ShangPharma in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ShangPharma.

Has ShangPharma been receiving favorable news coverage?

Media coverage about SHP stock has been trending positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. ShangPharma earned a coverage optimism score of 2.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the immediate future.

How do I buy shares of ShangPharma?

Shares of SHP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ShangPharma's stock price today?

One share of SHP stock can currently be purchased for approximately $23,300.00.

How can I contact ShangPharma?

ShangPharma's mailing address is No. 5 Building, 998 Halei Road Zhangjiang Hi-Tech Park, Pudong New Area 201203, SHANGHAI, SHA 201203, China. The company can be reached via phone at +86-21-51320088.

MarketBeat Community Rating for ShangPharma (NYSE SHP)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  106
MarketBeat's community ratings are surveys of what our community members think about ShangPharma and other stocks. Vote "Outperform" if you believe SHP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SHP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Featured Article: Put Option

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel